Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus

Japanese Journal of Infectious Diseases

Volumn 68, Issue 2, 2015, Pages 81-88

  Shirasago, Yoshitaka ^a,b   Sekizuka, Tsuyoshi ^a   Saito, Kyoko ^a   Suzuki, Tetsuro ^c   Wakita, Takaji ^a   Hanada, Kentaro ^a   Kuroda, Makoto ^a   Abe, Ryo ^b   Fukasawa, Masayoshi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CLONE; CELL CLONING; CELL ISOLATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CHARACTERIZATION; CELL LINE; GENE EXPRESSION; GENETICS; HEPACIVIRUS; LIVER CELL; METABOLISM; PHYSIOLOGY; PROCEDURES; VIROLOGY; VIRUS CULTURE; VIRUS LOAD; VIRUS REPLICATION;

CD81 ANTIGEN; CD81 PROTEIN, HUMAN;

ANTIGENS, CD81; CELL LINE; GENE EXPRESSION; HEPACIVIRUS; HEPATOCYTES; HUMANS; VIRAL LOAD; VIRUS CULTIVATION; VIRUS REPLICATION;

EID: 84921689278     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.JJID.2014.231     Document Type: Article

References (44)

1. Murray CL, Rice CM. Turning hepatitis C into a real virus. Annu Rev Microbiol. 2011;65:307-27.
2. World Health Organization. (Updated April 2014) Hepatitis C Fact sheet No. 164 (http://www.who.int/mediacentre/factsheets/ fs164/en/).
3. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264-73.e1.
4. Chatel-Chaix L, Germain MA, Gotte M, et al. Direct-acting and host-targeting HCV inhibitors: current and future directions. Curr Opin Virol. 2012;2:588-98.
5. Vermehren J, Sarrazin C. The role of resistance in HCV treat-ment. Best Pract Res Clin Gastroenterol. 2012;26:487-503.
6. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005;11:791-6.
7. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309:623-6.
8. Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A. 2005;102:9294-9.
9. Uprichard SL. Hepatitis C virus experimental model systems and antiviral drug research. Virol Sin. 2010;25:227-45.
10. Steinmann E, Pietschmann T. Cell culture systems for hepatitis C virus. Curr Top Microbiol Immunol. 2013;369:17-48.
11. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002;76:13001-14.
12. Sainz B Jr, Barretto N, Yu X, et al. Permissiveness of human hepatoma cell lines for HCV infection. Virol J. 2012;9:30.
13. Kambara H, Fukuhara T, Shiokawa M, et al. Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. J Virol. 2012;86:1382-93.
14. Fukuhara T, Kambara H, Shiokawa M, et al. Expression of microRNA miR-122 facilitates an efficient replication in non-hepatic cells upon infection with hepatitis C virus. J Virol. 2012;86:7918-33.
15. Shiokawa M, Fukuhara T, Ono C, et al. Novel permissive cell lines for complete propagation of hepatitis C virus. J Virol. 2014;88:5578-94.
16. Nitahara-Kasahara Y, Fukasawa M, Shinkai-Ouchi F, et al. Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells. Virology. 2009;383:319-27.
17. Kato T, Matsumura T, Heller T, et al. Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol. 2007;81:4405-11.
18. Kato T, Date T, Miyamoto M, et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology. 2003;125:1808-17.
19. Murakami Y, Fukasawa M, Kaneko Y, et al. Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle. Microbes Infect. 2013;15:45-55.
20. Wakita T, Wands JR. Specific inhibition of hepatitis C virus ex-pression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J Biol Chem. 1994;269:14205-10.
21. Kato T, Date T, Miyamoto M, et al. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J Clin Microbiol. 2005;43:5679-84.
22. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science. 1998;282:938-41.
23. Scarselli E, Ansuini H, Cerino R, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002;21:5017-25.
24. Evans MJ, von Hahn T, Tscherne DM, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature. 2007;446:801-5.
25. Ploss A, Evans MJ, Gaysinskaya VA, et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 2009;457:882-6.
26. Akazawa D, Date T, Morikawa K, et al. CD81 expression is im-portant for the permissiveness of Huh7 cell clones for heterogene-ous hepatitis C virus infection. J Virol. 2007;81:5036-45.
27. Sainz B, Jr Barretto N, Uprichard SL. Hepatitis C virus infection in phenotypically distinct Huh7 cell lines. PLoS One. 2009;4: e6561.
28. Bartenschlager R, Pietschmann T. Efficient hepatitis C virus cell culture system: what a difference the host cell makes. Proc Natl Acad Sci U S A. 2005;102:9739-40.
29. Sainz BJr, Chisari FV. Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J Virol. 2006;80:10253-7.
30. Chen H, Pei R, Chen X. Different responses of two highly permissive cell lines upon HCV infection. Virol Sin. 2013;28:202-8.
31. Inoue Y, Murakami K, Hmwe SS, et al. Transcriptomic compari-son of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies. Jpn J Infect Dis. 2007;60:173-8.
32. Murayama A, Sugiyama N, Yoshimura S, et al. A subclone of HuH-7 with enhanced intracellular hepatitis C virus production and evasion of virus related-cell cycle arrest. PLoS One. 2012;7: e52697.
33. Koutsoudakis G, Herrmann E, Kallis S, et al. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol. 2007;81:588-98.
34. Wu X, Robotham JM, Lee E, et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transi-tion to viral permissiveness during differentiation. PLoS Pathog. 2012;8:e1002617.
35. Roelandt P, Obeid S, Paeshuyse J, et al. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J Hepatol. 2012;57:246-51.
36. Schwartz RE, Trehan K, Andrus L, et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109:2544-8.
37. Girard S, Vossman E, Misek DE, et al. Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology. 2004;40: 708-18.
38. Wood JR, Melia WM, Wood SM, et al. Neurotensin and hepatocellular carcinoma. Lancet. 1984;1:687.
39. Adinolfi A, Adinolfi M, Lessof. Alpha-feto-protein during de-velopment and in disease. J Med Genet. 1975;12:138-51.
40. Lu Z, Zhou L, Killela P, et al. Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress. Cancer Res. 2009;69:9105-11.
41. Brychtova V, Vojtesek B, Hrstka R. Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett. 2011;304:1-7.
42. Pietschmann T, Lohmann V, Rutter G, et al. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol. 2001;75:1252-64.
43. Scholle F, Li K, Bodola F, et al. Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein ex-pression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J Virol. 2004;78:1513-24.
44. Nelson HB, Tang H. Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J Virol. 2006;80: 1181-90.